WCI
검색
Login
Sign Up
Sitemap
About Us
Message from the President
Mission
History
Charter
Bylaws
Organization
Linkage with other organizations
Membership
Membership
Organization Members
Individual Members
Student Members
Honorary Members
ICI
ICI History
ICI Chronicles
ICI Documents
ICI Photos
Publications
Newsletters
Brochures
Annual Activity Reports
Minutes
Adivisory Report
Training /
Seminar
Training Courses
Materials
Communication
Announcements
Events
RI Related News
RI Related News
Awards
Awards
Winners
Funding
Kinds of WCI funding
Acknowledgements
Community
RI Related News
RI Related News
Home > RI Related News > RI Related News
RI Related News
LOGIN
게시글 목록
No
TItle
Name
Date
Hit
680
LG Display Unveils Next-Generation OLED TV Display ‘OLED EX’
WCI Secretariat
2022/02/07
2626
679
Eckert & Ziegler Signs Exclusive Supply Agreement for Ytterbium-176
WCI Secretariat
2022/02/07
1764
678
Fusion Pharmaceuticals Announces Nomination Of First Targeted Alpha Therapy Candidate In Collaboration With AstraZeneca To Advance Into IND-Enabling Studies For Phase 1 Development
WCI Secretariat
2022/02/07
1708
677
Installation complete of new Isotope Production System at Bruce Power, paving way for production of life-saving medical isotopes
WCI Secretariat
2022/02/07
1691
676
Bruce Power completes shipment of Cobalt-60 for worldwide use in the ongoing fight against COVID-19 and cancer
WCI Secretariat
2022/02/07
1749
675
Plus Therapeutics significantly Expands Investigational Oncology Drug Pipeline Announces Significant Milestones toward CGMP Manufacture of Its Lead Investigational Radiotherapeutics
WCI Secretariat
2022/02/07
1798
674
Radiomedix and Orano Med Announce the Initiation of the Phase II Multi-Center Clinical Trial of Alphamedix™ for Targeted Alpha-Emitter Therapy of Neuroendocrine Cancers
WCI Secretariat
2022/02/07
1717
673
ITM and Grand Pharma Enter into a Commercialization Agreement for Targeted Radiopharmaceuticals in the Greater China Area
WCI Secretariat
2022/02/07
1791
672
ITM Announces First Patient Treated in Second Phase III Trial, COMPOSE, with ITM-11 (n.c.a. lutetium-177-edotreotide) for Treatment of Neuroendocrine Tumors
WCI Secretariat
2022/02/07
1784
671
ITM and Helmholtz Munich Sign Cooperation Agreement for the Clinical Development of Radiopharmaceutical Therapy to Treat Glioblastoma Multiforme
WCI Secretariat
2022/02/07
1744
670
Introducing Deuterium - to Make Drugs Have a Longer Effect
WCI Secretariat
2022/02/07
1793
669
ITM and ANSTO Announce Extension of Licensing Agreement for the Production and Supply of the Medical Radioisotope n.c.a. Lutetium-177
WCI Secretariat
2022/01/06
1809
668
ARTMS Inc. produces Zirconium-89 in US Commercial Nuclear Pharmacy using ARTMS’ QUANTM Irradiation System
WCI Secretariat
2022/01/06
1875
667
Clovis Oncology Highlights FAP-2286 Preclinical Data Presented At The Targeted Radiopharmaceuticals Summit
WCI Secretariat
2022/01/06
1924
666
Air Liquide Enters a long-term partnership to Secure its supply of helium-3
WCI Secretariat
2022/01/06
1904
First
Prev
1
2
3
4
5
6
7
8
9
10
Next
End (55 Page)
Name
Title
Contents
비밀글입니다!
글작성시 입력했던 비밀번호를 입력해주세요.
비밀번호 입력